+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

2024 POC Infectious Disease Diagnostics Forecasts for 100 Tests, Supplier Shares: Physician Offices, ER, OR, ICU, Ambulatory, Surgery and Birth Centers - Instrumentation Review, Emerging Technologies

  • PDF Icon

    Report

  • 835 Pages
  • July 2020
  • Region: Global
  • VPG Market Research
  • ID: 4856614

This new 835-page report contains 80 tables, and provides a comprehensive analysis of the POC infectious disease testing market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. The report is available by section, and can be customized to specific information needs and budget. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC infectious disease testing market.

Rationale

The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.

Market Segmentation Analysis

- Review of five POC market segments, including their dynamics, trends, structure, size, growth and major suppliers.

- Five-year test volume and reagent sales forecasts for major infectious disease tests by market segment:

- Physician Offices/Group Practices    
- Emergency Rooms
- Ambulatory Care Centers
- Surgery Centers 
- Birth Centers

Sales and Market Share Analysis
- Market shares of major infectious disease diagnostic reagent and instrument suppliers.

Current and Emerging Products
- Analysis of infectious disease diagnostic tests performed in POC testing locations.
- Review of leading infectious disease testing analyzers, both currently marketed and those in development, including their operating characteristics, features and selling prices.

Technology Review

- Emerging technologies and their applications for POC testing.
- Comprehensive listings of companies developing or marketing coagulation testing technologies and products, by assay.

Competitive Assessments

- Assessments of major suppliers and emerging market entrants including their sales, product portfolios, marketing tactics, joint ventures,
  and new products in R&D.

Strategic Recommendations

- Specific opportunities for new infectious disease testing instruments and reagent systems with potentially significant market appeal during the next five years.
- Design criteria for POC testing products.
- Alternative business expansion strategies.
- Potential market entry barriers and risks.

Methodology

This report is based on a combination of primary and secondary sources of information, including review of the latest technical and business publications, manufacturer product literature, industry analyst reports, and proprietary data files.

Contains 835 pages and 80 tables


Table of Contents

Introduction

Executive Summary

Rationale for Testing Decentralization
1. Overview
2. Regulatory Trends
3. Economic Trends
4. Demographic Trends
5. Technological Trends
6. Social Trends
7. Quality of Care
8. Defensive Medicine
9. Quality Control Issues

Worldwide Market and Technology Overview
1. AIDS
2. Adenovirus
3. Campylobacter
4. Candida
5. Chlamydia
6. Clostridium Difficile
7. Cytomegalovirus
8. Enteroviruses
9. Epstein-Barr Virus
10. Gonorrhea
11. Helicobacter Pylori
12. Hepatitis
13. Herpes Simplex Virus
14. Human Herpes Virus-6 (HHV-6)
15. Influenza Viruses
16. Legionella
17. Lyme Disease
18. Measles (Rubeola)
19. Meningitis
20. Mononucleosis
21. Mumps
22. Mycoplasma
23. Papillomaviruses
24. Pneumonia
25. Respiratory Syncytial Virus (RSV)
26. Rheumatoid Arthritis
27. Rotavirus (Reovirus)
28. Rubella (German Measles)
29. Salmonellosis
30. Shigellosis
31. Staphylococcus Aureus
32. Streptococci
33. Syphilis

Instrumentation: Infectious Disease Analyzers Manufactured by:


  •  Abbott
  •  Beckman Coulter/Danaher
  •  bioMeriuex
  •  Ortho
  •  Clinical Diagnostics
  •  Roche
  •  Siemens
  •  Tosoh
  •  Wallac
  • and other suppliers

Current and Emerging Technologies
1. Monoclonal Antibodies
2. Immunoassays
3. Dry Chemistry
4. Biosensors
5. IT and Automation
6. Molecular Diagnostics

Major Product Development Opportunities

Design Criteria for Decentralized Testing Products

Alternative Market Penetration Strategies

Potential Market Entry Barriers and Risks

Company Profiles

List of Tables


Samples

Loading
LOADING...

Companies Mentioned

  • Abbott
  • Affymetrix
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • bioMerieux
  • Bio-Rad
  • Cepheid
  • Diamedix
  • DiaSorin
  • Eiken Chemical
  • Elitech Group
  • Enzo Biochem
  • Fujirebio
  • Grifols
  • GSK Biologicals
  • Hologic
  • Leica Biosystems
  • Lonza
  • Ortho-Clinical Diagnostics
  • PerkinElmer
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • SeraCare
  • Siemens Healthineers
  • Takara Bio
  • Thermo Fisher
  • Wako